Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy

Blood (2019) 134 (Supplement_1): 2426.

https://doi.org/10.1182/blood-2019-129820

Published: 2019

Journal Articles

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Adam J Olszewski, MD, Anna Dorota Chorzalska, PhD, Annette S. Kim, MD PhD, Peter J. Quesenberry, MD, Mary L Lopresti, DO, Mary Anne Fenton, MD, John L. Reagan, MD, James Butera, MD, Ilyas Sahin, MD, Celine Hamel, CRA, Jordan Robison, CRA, Max Petersen, Patrycja Dubielecka, PhD

Blood (2018) 132 (Supplement 1): 3841.

https://doi.org/10.1182/blood-2018-99-111436

Published: 2018

Journal Articles

Adjuvant Chemotherapy Administration and Survival Outcomes in Lymphoma Survivors with Common Solid Tumors: A Population-Based Study

Mengyang Di, MD PhD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 621.

https://doi.org/10.1182/blood-2018-99-114250

Published: 2018

Journal Articles

HIV-Related Primary Diffuse Large B Cell Lymphoma of the Appendix. What Can We Learn?

Michelle Janania Martinez, MD, Adolfo E Diaz, MD, Cynthia Forker, MD

Blood (2018) 132 (Supplement 1): 5423.

https://doi.org/10.1182/blood-2018-99-119865

Published: 2018

Journal Articles

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Faye A Sharpley, MBBChir, MA, MRCP, MSc BA, Pedro Neffa, Fotis Panitsas, Jaimal Kothari, David Cutter, Roberta Shcolnik Szor, Manil Subesinghe, MBBS, MRCP, FRCR., Gracia Martinez, MD, Vanderson Rocha, MD PhD, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 5379.

https://doi.org/10.1182/blood.V130.Suppl_1.5379.5379

Published: 2017

Journal Articles

Modified Khorana Models for Prediction of Cancer-Associated Venous Thromboembolism: An Exploratory Study

Gabriela Sanchez Petitto, MD, Carmen P Escalante, MD, Marsha N Richardson, MSW, Cristhiam Rojas Hernandez, MD

Blood (2017) 130 (Supplement 1): 4635.

https://doi.org/10.1182/blood.V130.Suppl_1.4635.4635

Published: 2017

Journal Articles

Adjuvant Chemotherapy in the Treatment of Solitary Bone Plasmacytoma

Kayane Mheidly, Thierry Lamy, Martine Escoffre, Mathilde Hunault, MD PhD, Lotfi Benboubker, MD PhD, Maxime Esvan, Mohamed Benchalal, Philippe Moreau, Olivier Decaux, MD PhD

Blood (2016) 128 (22): 4514.

https://doi.org/10.1182/blood.V128.22.4514.4514

Published: 2016

Journal Articles

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Suneel Deepak Kamath, MD, Elizabeth H. Cull, MD, Brady L. Stein, MD, Robert Lewandowski, MD, Brandon McMahon, MD

Blood (2016) 128 (22): 1423.

https://doi.org/10.1182/blood.V128.22.1423.1423

Published: 2016

Journal Articles

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Philippe Debourdeau, MD, Marc Espié, MD, Sylvie Chevret, MD PhD, Joseph Gligorov, MD PhD, Antoine Elias, MD PhD, Pierre Francois Dupré, MD, Joel Le Long, MD, Sandrine Lavau-Denes, MD, Marie-Antoinette Sevestre, MD PhD, Laurent Bastit, MD, Issa Kalidi, MD, Corinne Frere, MD PhD, Dominique Farge, MD PhD

Blood (2016) 128 (22): 2607.

https://doi.org/10.1182/blood.V128.22.2607.2607

Published: 2016

Journal Articles

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

Preetesh Jain, MBBS,MDDM,PhD, Keyur P. Patel, MD PhD, Andrew Futreal, PhD, Curtis Gumbs, Shimin Hu, PhD MD, Carlos Bueso Ramos, MD, Michael Wang, MD, Jorge Romaguera, Luis E. Fayad, MD, Robert Z. Orlowski, PhD, MD, Jeffrey Medeiros, Nathan Fowler, MD

Blood (2015) 126 (23): 2700.

https://doi.org/10.1182/blood.V126.23.2700.2700

Published: 2015

Journal Articles

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Katarina Sevcikova, MD, Zuo Zhuang, MD PhD, Guillermo Garcia-Manero, MD, Ricardo Alvarez, MD, Hagop M. Kantarjian, MD, Mego Michal, MD, Constance Albarracin, MD PhD, Guilin Tang, MD, Sara S. Strom, PhD, James M. Reuben, PhD, Joseph D Khoury, MD

Blood (2014) 124 (21): 962.

https://doi.org/10.1182/blood.V124.21.962.962

Published: 2014

Journal Articles

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Jingjing Wang, Mei Dong, MD, Xiaohui He, MD, Weihu Wang, MD, Peng Liu, MD, Jianliang Yang, MD, Yan Qin, MD, Lin Gui, MD, Sheng Yang, MD, Yexiong Li, MD PhD, Yuankai Shi, MD PhD, Lugui Qiu, MD

Blood (2014) 124 (21): 3071.

https://doi.org/10.1182/blood.V124.21.3071.3071

Published: 2014

Journal Articles

Low Serum Vitamin B12 With Supplement In Pernicious Anemia

Ahmad Jajeh, MD

Blood (2013) 122 (21): 4722.

https://doi.org/10.1182/blood.V122.21.4722.4722

Published: 2013

Journal Articles

Chronic Myeloid Leukemia After Adjuvant Treatment For Breast Cancer: Is It Therapy Related?

Ashwin Kishtagari, MBBS, Isaac Alexander Bowman, MD, Martin S. Tallman, MD, Dan Douer, MD, Ellin Berman, MD, Peter G. Maslak, M.D., Renier J Brentjens, MD, PhD, Eytan M Stein, MD

Blood (2013) 122 (21): 2740.

https://doi.org/10.1182/blood.V122.21.2740.2740

Published: 2013

Journal Articles

Adjuvant CD49d Blockade Eradicates Chemoresistant ALL

Yao-Te Hsieh, Eugene Park, Enzi Jiang, MD, PhD, Katrin Dauber, Doreen Chudziak, Paul Schaefer, Lars Klemm, Carlton Scharman, Eun-Suk Kang, MD, PhD, Hong-Hoe Koo, MD, PhD, Mignon L. Loh, M.D., Wolf Karsten Hofmann, MD, PhD, Nora Heisterkamp, Markus Muschen, MD, Hiroyuki Shimada, MD, Halvard Bonig, MD, MA, Yong-Mi Kim, MD, MPH

Blood (2010) 116 (21): 869.

https://doi.org/10.1182/blood.V116.21.869.869

Published: 2010

Journal Articles

Clinicopathologic Characteristics and Outcome of Histiocytic and Dendritic Cell Neoplasms: A Single Institutional Experience.

Mojdeh Naghashpour, MD, PhD, Reza Setoodeh, MD, Lynn C. Moscinski, MD, Lubomir Sokol, MD, PhD

Blood (2010) 116 (21): 2813.

https://doi.org/10.1182/blood.V116.21.2813.2813

Published: 2010

Journal Articles

Short Course Adjuvant Chemotherapy for Localized Diffuse Large B-Cell Lymphoma After Complete Resection.

Jungmin Jo, M.D, Changhoon Yoo, M.D, Yongchel Ahn, M.D, Seong Joon Park, M.D, Dae Ho Lee, M.D, Sang-We Kim, M.D, Jungsin Lee, MD, Cheolwon Suh, MD

Blood (2010) 116 (21): 2824.

https://doi.org/10.1182/blood.V116.21.2824.2824

Published: 2010

Journal Articles

Breast Cancer Patients Undergoing Adjuvant Chemotherapy Do Not Acquire Activated Protein C Resistance (APC-R).

Madhu N Belur Shivananda, MBBS, MD, Theodore Bell, MS, Edith Sielsch, CRNP, Diane Gaspari, Amir Tabatabai, MD

Blood (2009) 114 (22): 5058.

https://doi.org/10.1182/blood.V114.22.5058.5058

Published: 2009

Journal Articles

Significant Expansion of Myeloid Derived Suppressor Cells in Patients with High- Risk Breast Cancer Treated with Dose Dense Adjuvant Chemotherapy

James E Talmadge, Elizabeth Reed, MD, Kenneth Cowan, Dmitry Gabrilovich, Phyllis Warkentin, William E. Janssen, PhD, James Wisecarver, James Anderson, Mary Mailliard, Sarah Maas, Orhan Turken, Uger Coskun

Blood (2008) 112 (11): 4653.

https://doi.org/10.1182/blood.V112.11.4653.4653

Published: 2008

Journal Articles

Risk Factors for Febrile Neutropenia among Breast, Lung, and Colorectal Cancer Patients: A Retrospective Analysis of Health Plan Databases

Scott Davi d Ramsey, Jeannine S McCune, David K Blough, Lauren C Clarke, Cara L McDermott, Sean D Sullivan

Blood (2008) 112 (11): 4696.

https://doi.org/10.1182/blood.V112.11.4696.4696

Published: 2008

NARROW

A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Adjuvant Chemotherapy Administration and Survival Outcomes in Lymphoma Survivors with Common Solid Tumors: A Population-Based Study

HIV-Related Primary Diffuse Large B Cell Lymphoma of the Appendix. What Can We Learn?

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Modified Khorana Models for Prediction of Cancer-Associated Venous Thromboembolism: An Exploratory Study

Adjuvant Chemotherapy in the Treatment of Solitary Bone Plasmacytoma

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Low Serum Vitamin B12 With Supplement In Pernicious Anemia

Chronic Myeloid Leukemia After Adjuvant Treatment For Breast Cancer: Is It Therapy Related?

Adjuvant CD49d Blockade Eradicates Chemoresistant ALL

Clinicopathologic Characteristics and Outcome of Histiocytic and Dendritic Cell Neoplasms: A Single Institutional Experience.

Short Course Adjuvant Chemotherapy for Localized Diffuse Large B-Cell Lymphoma After Complete Resection.

Breast Cancer Patients Undergoing Adjuvant Chemotherapy Do Not Acquire Activated Protein C Resistance (APC-R).

Significant Expansion of Myeloid Derived Suppressor Cells in Patients with High- Risk Breast Cancer Treated with Dose Dense Adjuvant Chemotherapy

Risk Factors for Febrile Neutropenia among Breast, Lung, and Colorectal Cancer Patients: A Retrospective Analysis of Health Plan Databases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only